Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Homology Medicines Inc.

    NASDAQ: FIXX · Real-Time Price · USD
    0.93
    0.00 (0.26%)
    At close: Mar 25, 2024, 8:00 PM

    Homology Medicines Statistics

    Share Statistics

    Homology Medicines has 3.23M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 3.23M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 50

    FTD / Avg. Volume

    n/a
    		 0.17%

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is -0.03 and the forward PE ratio is null. Homology Medicines's PEG ratio is 0.

    PE Ratio

    n/a
    		 -0.03

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 3.04

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 0.05

    P/FCF Ratio

    n/a
    		 -0.04

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Homology Medicines has an Enterprise Value (EV) of -34.43M.

    EV / Sales

    n/a
    		 -29.79

    EV / EBITDA

    n/a
    		 0.38

    EV / EBIT

    n/a
    		 0.36

    EV / FCF

    n/a
    		 0.36

    Financial Position

    The company has a current ratio of 7.25, with a Debt / Equity ratio of 0.02.

    Current Ratio

    n/a
    		 7.25

    Quick Ratio

    n/a
    		 7.25

    Debt / Equity

    n/a
    		 0.02

    Debt / EBITDA

    n/a
    		 -0.01

    Debt / FCF

    n/a
    		 -0.01

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is -154.76% and Return on Invested Capital is -160.78%.

    Return on Equity

    n/a
    		 -154.76%

    Return on Assets

    n/a
    		 -36.9%

    Return on Invested Capital

    n/a
    		 -160.78%

    Revenue Per Employee

    n/a
    		 $165,142.86

    Profits Per Employee

    n/a
    		 $-16,137,285.71

    Employee Count

    n/a
    		 7

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 25.88M

    Effective Tax Rate

    n/a
    		 -29.72%

    Stock Price Statistics

    The stock price has increased by -0.5% in the last 52 weeks. The beta is -0.11, so Homology Medicines's price volatility has been lower than the market average.

    Beta

    n/a
    		 -0.11

    52-Week Price Change

    n/a
    		 -0.5%

    50-Day Moving Average

    n/a
    		 0.78

    200-Day Moving Average

    n/a
    		 0.91

    Relative Strength Index (RSI)

    n/a
    		 65.97

    Average Volume (20 Days)

    n/a
    		 29,535

    Income Statement

    In the last 12 months, Homology Medicines had revenue of 1.16M and earned -112.96M in profits. Earnings per share was -351.57.

    Revenue

    n/a
    		 1.16M

    Gross Profit

    n/a
    		 578K

    Operating Income

    n/a
    		 -92.1M

    Net Income

    n/a
    		 -112.96M

    EBITDA

    n/a
    		 -91.52M

    EBIT

    n/a
    		 n/a

    Earnings Per Share (EPS)

    n/a
    		 -351.57
    Full Income Statement

    Balance Sheet

    The company has 39.27M in cash and 1.32M in debt, giving a net cash position of 37.95M.

    Cash & Cash Equivalents

    n/a
    		 39.27M

    Total Debt

    n/a
    		 1.32M

    Net Cash

    n/a
    		 37.95M

    Retained Earnings

    n/a
    		 -542.1M

    Total Assets

    n/a
    		 152.33M

    Working Capital

    n/a
    		 105.09M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -96.23M and capital expenditures -228K, giving a free cash flow of -96.46M.

    Operating Cash Flow

    n/a
    		 -96.23M

    Capital Expenditures

    n/a
    		 -228K

    Free Cash Flow

    n/a
    		 -96.46M

    FCF Per Share

    n/a
    		 -300.21
    Full Cash Flow Statement

    Margins

    Gross margin is 50%, with operating and profit margins of -7967.3% and -9771.71%.

    Gross Margin

    n/a
    		 50%

    Operating Margin

    n/a
    		 -7967.3%

    Pretax Margin

    n/a
    		 -7532.87%

    Profit Margin

    n/a
    		 -9771.71%

    EBITDA Margin

    n/a
    		 -7917.3%

    EBIT Margin

    n/a
    		 -7967.3%

    FCF Margin

    n/a
    		 -8344.12%

    Dividends & Yields

    FIXX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 -3213.62%

    FCF Yield

    n/a
    		 -2744.13%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for FIXX.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Mar 25, 2024. It was a backward split with a ratio of 1:18.

    Last Split Date

    n/a
    		 Mar 25, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:18

    Scores

    Altman Z-Score

    n/a
    		 -2.25

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist